X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Disease modifying therapies for the management of multiple sclerosis save money and improve patient outcomes

By Samantha Dougherty  |    October 24, 2017
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recent study comparing the effectiveness of oral and...   Read More

How do multiple sclerosis patients define value?

By Lauren Neves  |    February 24, 2017
There are crucial conversations occurring in the health care system about how value is defined. To explore how multiple sclerosis (MS) patients, providers and payers view value, Real Endpoints...   Read More

Focusing on patients and progress on World Hepatitis Day

By Hannah Mooney  |    July 28, 2016
World Hepatitis Day is a unique opportunity to take stock of the recent advancements in new treatments and cures to combat versions of hepatitis. Founded by the World Hepatitis Alliance, World...   Read More

What “value” means to me

By Priscilla VanderVeer  |    March 17, 2016
It’s March, which means it is National Kidney Month. More than 661,000 Americans have kidney failure. Every day, approximately 13 people die waiting for a kidney transplant. I am lucky to not be...   Read More

New report celebrates a decade of progress in chronic diseases

By Holly Campbell  |    February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...   Read More

Medicare Monday: Managing Chronic Conditions

By Allyson Funk  |    June 22, 2015
According to the Centers for Disease Control and Prevention, two in three older Americans live with multiple chronic conditions. Chronic conditions may include Alzheimer’s and dementia, arthritis,...   Read More

What Access and Affordability Means for Chronic Disease Patients

By Allyson Funk  |    March 12, 2015
For the nearly one in two American adults living with at least one chronic illness, affordability and access to medicine is crucial. Unfortunately, if you have a chronic condition, there may be...   Read More

New Report Highlights a Decade of Innovation in Rare Diseases

By Stephanie Fischer  |    March 5, 2015
Despite Scientific Challenges, Biopharmaceutical Researchers Making Progress against Rare Disease While any given rare disease affects fewer than 200,000 people in the U.S., rare diseases...   Read More

Access to Combination Therapies May Be Limited with Exchange Coverage

By Allyson Funk  |    October 23, 2014
Would you rather take three different pills a day, following specific instructions for each, making sure you don’t forget one or just one pill a day that has the same effect? As drug development...   Read More

More than 430 Medicines in Development to Treat Chronic Diseases Affecting Older Americans

By Robert Zirkelbach  |    June 18, 2014
Aging is a fact of life but the good news is that life expectancy continues to climb and more and more Americans are living fuller, richer lives thanks in large part to innovative medicines being...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates